154 related articles for article (PubMed ID: 32031980)
1. Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2.
Wihastuti TA; Amiruddin R; Cesa FY; Alkaf AI; Setiawan M; Heriansyah T
J Basic Clin Physiol Pharmacol; 2020 Feb; 30(6):. PubMed ID: 32031980
[TBL] [Abstract][Full Text] [Related]
2. Reduction in Vasa Vasorum Angiogenesis by Lp-PLA2 Selective Inhibitor Through The HIF-1α and VEGF Expression Under Dyslipidemic Conditions in Atherosclerosis Pathogenesis.
Heriansyah T; Nafisatuzzamrudah N; Aini FN; Ridwan M; Primardhika RF; Wijayanti M; Bekti RS; Wihastuti TA
Cardiovasc Hematol Agents Med Chem; 2018; 16(2):114-119. PubMed ID: 30394217
[TBL] [Abstract][Full Text] [Related]
3. Vasa vasorum anti-angiogenesis through H₂O₂, HIF-1α, NF-κB, and iNOS inhibition by mangosteen pericarp ethanolic extract (Garcinia mangostana Linn) in hypercholesterol-diet-given Rattus norvegicus Wistar strain.
Wihastuti TA; Sargowo D; Tjokroprawiro A; Permatasari N; Widodo MA; Soeharto S
Vasc Health Risk Manag; 2014; 10():523-31. PubMed ID: 25187725
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis Inhibitor, Endostar, Prevents Vasa Vasorum Neovascularization in a Swine Atherosclerosis Model.
Xu X; Mao W; Chai Y; Dai J; Chen Q; Wang L; Zhuang Q; Pan Y; Chen M; Ni G; Huang Z
J Atheroscler Thromb; 2015; 22(10):1100-12. PubMed ID: 26016418
[TBL] [Abstract][Full Text] [Related]
5. The reduction of aorta histopathological images through inhibition of reactive oxygen species formation in hypercholesterolemia rattus norvegicus treated with polysaccharide peptide of Ganoderma lucidum.
Andri Wihastuti T; Sargowo D; Heriansyah T; Eka Aziza Y; Puspitarini D; Nur Iwana A; Astrida Evitasari L
Iran J Basic Med Sci; 2015 May; 18(5):514-9. PubMed ID: 26124939
[TBL] [Abstract][Full Text] [Related]
6. Role of lipids and intraplaque hypoxia in the formation of neovascularization in atherosclerosis.
Chistiakov DA; Melnichenko AA; Myasoedova VA; Grechko AV; Orekhov AN
Ann Med; 2017 Dec; 49(8):661-677. PubMed ID: 28797175
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor-2 is required for vasa vasorum plexus stability in hypercholesterolemic mice.
Mollmark JI; Park AJ; Kim J; Wang TZ; Katzenell S; Shipman SL; Zagorchev LG; Simons M; Mulligan-Kehoe MJ
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2644-51. PubMed ID: 22982464
[TBL] [Abstract][Full Text] [Related]
8. Polysaccharide peptide (PsP) G
Heriansyah T; Nurwidyaningtyas W; Sargowo D; Tjahjono CT; Wihastuti TA
Vasc Health Risk Manag; 2019; 15():419-427. PubMed ID: 31632046
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycaemia is associated with impaired vasa vasorum neovascularization and accelerated atherosclerosis in apolipoprotein-E deficient mice.
Veerman KJ; Venegas-Pino DE; Shi Y; Khan MI; Gerstein HC; Werstuck GH
Atherosclerosis; 2013 Apr; 227(2):250-8. PubMed ID: 23411040
[TBL] [Abstract][Full Text] [Related]
10. Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease.
Sedding DG; Boyle EC; Demandt JAF; Sluimer JC; Dutzmann J; Haverich A; Bauersachs J
Front Immunol; 2018; 9():706. PubMed ID: 29719532
[TBL] [Abstract][Full Text] [Related]
11. Vasa vasorum in atherosclerosis and clinical significance.
Xu J; Lu X; Shi GP
Int J Mol Sci; 2015 May; 16(5):11574-608. PubMed ID: 26006236
[TBL] [Abstract][Full Text] [Related]
12. [Danlou Tablet Fought against Inflammatory Reaction in Atherosclerosis Rats with Intermingled Phlegm and Blood Stasis Syndrome and Its Mechanism Study].
Chen J; Cai HW; Miao J; Xu XM; Mao W
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jun; 36(6):703-8. PubMed ID: 27491230
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance adipocyte-derived exosomes aggravate atherosclerosis by increasing vasa vasorum angiogenesis in diabetic ApoE
Wang F; Chen FF; Shang YY; Li Y; Wang ZH; Han L; Li YH; Zhang L; Ti Y; Zhang W; Zhong M
Int J Cardiol; 2018 Aug; 265():181-187. PubMed ID: 29685689
[TBL] [Abstract][Full Text] [Related]
14. Targeting vasa vasorum dysfunction to prevent atherosclerosis.
Boyle EC; Sedding DG; Haverich A
Vascul Pharmacol; 2017 Sep; 96-98():5-10. PubMed ID: 28830735
[TBL] [Abstract][Full Text] [Related]
15. Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis.
Zhang J; Xu DL; Liu XB; Bi SJ; Zhao T; Sui SJ; Ji XP; Lu QH
Yonsei Med J; 2016 Mar; 57(2):321-7. PubMed ID: 26847282
[TBL] [Abstract][Full Text] [Related]
16. Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia.
Herrmann J; Best PJ; Ritman EL; Holmes DR; Lerman LO; Lerman A
J Am Coll Cardiol; 2002 May; 39(9):1555-61. PubMed ID: 11985922
[TBL] [Abstract][Full Text] [Related]
17. Early Microvascular Dysfunction: Is the Vasa Vasorum a "Missing Link" in Insulin Resistance and Atherosclerosis.
Owusu J; Barrett E
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299190
[TBL] [Abstract][Full Text] [Related]
18. Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia.
Gössl M; Herrmann J; Tang H; Versari D; Galili O; Mannheim D; Rajkumar SV; Lerman LO; Lerman A
Basic Res Cardiol; 2009 Nov; 104(6):695-706. PubMed ID: 19458984
[TBL] [Abstract][Full Text] [Related]
19. The vasa vasorum in diseased and nondiseased arteries.
Mulligan-Kehoe MJ
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H295-305. PubMed ID: 19940078
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effects of polysaccharide peptides (PsP) of
Wihastuti TA; Heriansyah T
Heart Int; 2017; 12(1):e1-e7. PubMed ID: 29114382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
